$5.4 million settlement reached in lawsuits against HealthVest, Healthcare International.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to S Lutz.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Home infusion has been one of healthcare's healthiest businesses, but providers are concerned about the future in light of new "safe harbor" guidelines and recent crackdowns by the HHS inspector general's office. Despite that uncertainty, the industry continues to prosper: Revenues have risen at an estimated 25% annual rate, thanks to home infusion's ability to get patients out of hospitals quicker.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.